Current management of shoulder adhesive capsulitis: a randomized, triple-blind placebo-controlled trial

Riyadh A Almashni,Anwar A Alghamdi,Mohamad W Hijazi,Meshal A Almeshal,Anfal J Alsharif,Nasser O Altufayl,Abdullah W Calacattawi,Shahd A Abdulwahab,Elaf J Alsharif,Hisham A Almuzayyen

doi:10.18203/2394-6040.ijcmph20183392

Abstract

This review is aiming to discuss both operative and non-operative current management of this adhesive capsulitis. The present review was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) declaration standards for systematic reviews. A systematic search for the terms adhesive capsulitis, frozen shoulder, glucocorticoid, non-operative operative, current management, and management of systematic review in different databases, including MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL), were searched up to March 2018 for published and unpublished studies and without language restrictions. The majority of the trials show level 2 [mid-level] evidence, positive results were found for intra-articular corticosteroid injections combined with shoulder mobility and stretching exercises are more eﬀective in providing short-term (4-6 weeks) pain relief and improved function compared to shoulder mobility and stretching exercises alone. On the basis of current clinical evidence, this systematic review suggests that there is no strong evidence to support or refute the current practice in term of adhesive capsulitis management. As there is a need of further research in this issue and to have clear uniformed prospective about the adhesive capsulitis.

Highlights

Adhesive capsulitis known as frozen shoulder is a musculoskeletal condition that has a disabling capability, which characterized by a painful, gradual restriction of both active and passive movements of the glenohumeral joint
Adhesive capsulitis may be associated with increased risk of stroke based on prospective cohort study, 10,935 patients >40 years old with adhesive capsulitis and no history of rheumatologic disorder in past year or any history of stroke and 32,805 controls followed for 3 years; stroke in 5.3% with adhesive capsulitis vs. 3.7% controls (p=0.002).[4]
Studies has been independently rated as being high quality by an established evaluation process based on the DynaMed criteria and it's about levels of evidence, as following: Level A: High-quality randomized controlled trial (RCT) that considers all important outcomes

Summary

Introduction

Adhesive capsulitis known as frozen shoulder is a musculoskeletal condition that has a disabling capability, which characterized by a painful, gradual restriction of both active and passive movements of the glenohumeral joint. Idiopathic frozen shoulder is the most common cause of painful restriction of the shoulder movement and is characterized by an inflammatory contracture of the shoulder capsule and ligaments, causing a reduction in the available intra-articular volume, and limitation of the glenohumeral movement.[1]. As there are many accepted standard forms of management for shoulder disorders, including nonsteroidal anti-inflammatory drugs, corticosteroid injections, and physiotherapy, yet evidence of their efficacy is not well established, and Because there is little evidence to support or refute the efficacy of common current interventions for shoulder pain and management of Adhesive capsulitis we conducted this review discusses both operative and non-operative current management of this shoulder condition, aiming to clarify What is the types of current available management for adhesive capsulitis, the effectiveness of non-operative treatment for Adhesive Capsulitis, and treatment prognosis on pain relief and range of motion improvement

Methods

Results

Conclusion